FDA Approves Broad‑spectrum Parasiticide For Cats
AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

The FDA approved Felpreva, a prescription topical parasiticide from Vetoquinol USA that combines three active ingredients to treat or control several parasites in cats. The company says it is expected to be available through U.S. distributors by 2027; its labeled coverage periods differ by parasite.

The U.S. Food and Drug Administration has approved Felpreva, a prescription topical parasiticide for cats made by Vetoquinol USA, the company announced. The treatment combines three active ingredients intended to address worms, fleas, ticks and mites, with different durations of control specified for certain parasites.

Before you orderOffer from Amazon

Get pet supplies delivered free with Prime

  • Fast, free delivery on millions of items
  • Prime Video, Amazon Music and more included
  • Member-only deals all year
Start your free Prime trial Free trial for eligible customers · Cancel anytime
As an affiliate, we earn on qualifying purchases.

Felpreva contains emodepside to treat roundworms, praziquantel to treat tapeworms and tigolaner to control fleas, ticks and mites, according to the product information reported by Veterinary Practice News. It is a topical solution and is available by prescription, rather than as an over-the-counter product.

The reported labeling says the product treats and prevents fleas and treats and controls black-legged ticks for 12 weeks. It treats and controls lone star ticks for eight weeks in cats that are at least six months old and weigh at least 2.2 pounds. Those age and weight limits apply to the stated lone star tick use; the source report does not provide full prescribing information for every use.

Vetoquinol said Felpreva will be available for purchase from distributors by 2027. The announcement identifies no specific launch date, distributor, price or package size. The FDA approval and the company’s planned availability are separate facts: approval has been announced, while commercial availability remains in the future.

At a glance
announcementWhen: FDA approval announced; distributor ava…
The developmentThe FDA approved Vetoquinol USA’s Felpreva topical solution, a three-ingredient prescription parasiticide for cats.

One Application, Several Parasites

The approval gives veterinarians another prescription option that combines treatment or control for several parasite groups in one topical product. For cat owners, a product covering multiple parasites could simplify prevention schedules, although the practical effect will depend on the animal’s needs, the product label and veterinary advice.

Vetoquinol country manager Michael Maginnis described the product as a way to reduce complexity through fewer applications and broad-spectrum coverage. That is the company’s characterization, not a claim that every cat will need fewer treatments overall. Felpreva’s reported coverage periods vary by parasite, and its prescription status means a veterinarian must determine whether it is appropriate for a particular cat.

The approval also matters because the stated minimum age and weight for the lone star tick indication narrow which cats qualify for that use. Owners should not assume the same duration or eligibility applies to every parasite covered by the product. The full label and a veterinarian’s assessment will guide use.

Products Worth Considering

As an affiliate, we earn on qualifying purchases.

Three Ingredients, Different Targets

The product brings together three active ingredients with distinct roles: emodepside for roundworms, praziquantel for tapeworms and tigolaner for external parasites listed in the report. The combined formulation is presented as a broad-spectrum approach, but the source does not say that each ingredient targets every parasite named in the announcement.

Veterinary Practice News reported the approval based on an announcement from Vetoquinol USA. The company’s announcement gives the product’s key ingredients, reported parasite coverage and planned distribution timing. It does not supply the full FDA label, clinical-study results, contraindications or detailed directions. Those materials are needed to assess the complete terms of approval and how the treatment should be used.

Label Details and Launch Timing

The source report does not provide the complete FDA-approved prescribing information, including all indications, application directions, warnings, possible adverse effects or limits on use. It also does not describe the evidence reviewed by the FDA or specify which mite species are covered. These details should not be inferred from the broad summary of ingredients and parasite targets.

Commercial timing is also not exact: Vetoquinol said the product will be available through distributors by 2027, but did not name a launch day or confirm which distributors will carry it. Pricing and geographic availability within the United States were not reported. The stated eight- and 12-week periods apply to the particular parasite claims described, not necessarily to all of Felpreva’s uses.

Distribution Expected by 2027

Vetoquinol’s stated next milestone is making Felpreva available for purchase from distributors by 2027. The company has not announced a more precise timetable in the source material. Veterinarians and cat owners will need the product’s complete prescribing information to review eligibility, directions and safety details once it is offered.

Until then, owners should ask a veterinarian which parasite-control products suit their cat, particularly if the animal is young, small, has health conditions or takes other medicines. Approval of a new product does not replace individualized veterinary advice.

Key Questions

What is Felpreva?

Felpreva is a prescription topical parasiticide for cats approved by the FDA, according to Vetoquinol USA. It combines emodepside, praziquantel and tigolaner.

Which parasites does Felpreva target?

The reported product information lists emodepside for roundworms, praziquantel for tapeworms and tigolaner for control of fleas, ticks and mites. The report says it treats and prevents fleas, with specific reported control periods for black-legged and lone star ticks.

How long does the reported tick control last?

The report says Felpreva treats and controls black-legged ticks for 12 weeks and lone star ticks for eight weeks. The lone star tick use is reported for cats at least six months old and weighing at least 2.2 pounds.

When will Felpreva be available?

Vetoquinol said it expects Felpreva to be available from distributors by 2027. No exact date, price or distributor list was provided in the source report.

Can cat owners buy Felpreva without a prescription?

No. The source describes Felpreva as prescription-only. Cat owners should consult a veterinarian about whether it is suitable for their animal and follow the approved product information.

Source: veterinarypracticenews.com

Pet-care content is informational — consult your veterinarian for advice about your animal.
You May Also Like

The Uniqueness of Small Batch Raw Cat Food

Discover the benefits of small batch raw cat food, crafted with locally sourced, premium ingredients for optimal feline health – a game-changer for cat owners seeking top-notch nutrition.

Cat Spaying Costs Explored – How Much Is It?

AIThis post was created with the assistance of artificial intelligence (AI).Did you…

10 Smells Cats Hate

Keen to discover which scents make cats crinkle their noses? Uncover the top 10 smells cats hate and keep your feline friends content.

Can Cats Eat Ham?

Satisfy your curiosity about whether cats can eat ham and discover important considerations for their health and well-being.